First Brazilian Case Report of Unrelated Patients with Identical ISG15 Mutation
Background ISG15 deficiency is a mixed syndrome of Mendelian susceptibility to mycobacterial infections (MSMD), a rare inherited condition characterized primarily by recurrent infections from low-virulence mycobacteria and monogenic type I interferonopathy. Objective To characterize the laboratory a...
Saved in:
| Published in | Journal of clinical immunology Vol. 45; no. 1; p. 21 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
New York
Springer US
01.12.2025
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0271-9142 1573-2592 1573-2592 |
| DOI | 10.1007/s10875-024-01811-9 |
Cover
| Abstract | Background
ISG15 deficiency is a mixed syndrome of Mendelian susceptibility to mycobacterial infections (MSMD), a rare inherited condition characterized primarily by recurrent infections from low-virulence mycobacteria and monogenic type I interferonopathy.
Objective
To characterize the laboratory and molecular features of two patients from different families affected by the same ISG15 variant.
Methods
We began with clinical characterization and investigation, assessed IL-12/IFN-γ production, performed genetic characterization through WES and Sanger sequencing, conducted an in silico molecular analysis of the genetic ISG15 variant’s protein impact, and utilized RNAseq for transcriptome analysis to understand pathway impacts on
ISG15
-deficient subjects from unrelated families.
Results
A mutation in the ISG15 gene was identified, affecting two patients treated in different hospitals and cities in Brazil (Fortaleza and Sao Paulo), who are also members of unrelated families. Both patients showed low IFN-γ production when stimulated with BCG or BCG + IL-12.
ISG15
deficiency presented with two distinct clinical phenotypes: infectious and neurological. It was identified that both patients are homozygous for the variant (c.83 T > A). Furthermore, it was observed that the mutant protein p.L28Q results in an unstable protein with increased flexibility (ΔΔG: -2.400 kcal/mol). Transcriptome analysis revealed 1321 differentially expressed genes, with significant upregulation in interferon pathways, showing higher expression in patients compared to controls.
Conclusion
This study describes the first reported cases in Brazil of two unrelated patients with the same
ISG15
mutation c.83 T > A, exhibiting infectious features such as mycobacterial infections and systemic candidiasis, neurological findings, and skin lesions, without adverse reactions to the BCG vaccine.
Clinical Implications
Reporting
ISG15
gene mutations in Brazilian patients enhances understanding of genetic susceptibilities, guiding effective diagnostics and treatment. Identifying high-risk individuals aids clinical practices, genetic counseling, and influences public health policies.
Capsule Summary
We have identified the first case in Brazil of the same
ISG15
variant c.83 T > A that was identified in two unrelated patients with distinct clinical phenotypes, infectious and neurological. |
|---|---|
| AbstractList | BACKGROUND: ISG15 deficiency is a mixed syndrome of Mendelian susceptibility to mycobacterial infections (MSMD), a rare inherited condition characterized primarily by recurrent infections from low-virulence mycobacteria and monogenic type I interferonopathy. OBJECTIVE: To characterize the laboratory and molecular features of two patients from different families affected by the same ISG15 variant. METHODS: We began with clinical characterization and investigation, assessed IL-12/IFN-γ production, performed genetic characterization through WES and Sanger sequencing, conducted an in silico molecular analysis of the genetic ISG15 variant's protein impact, and utilized RNAseq for transcriptome analysis to understand pathway impacts on ISG15-deficient subjects from unrelated families. RESULTS: A mutation in the ISG15 gene was identified, affecting two patients treated in different hospitals and cities in Brazil (Fortaleza and Sao Paulo), who are also members of unrelated families. Both patients showed low IFN-γ production when stimulated with BCG or BCG + IL-12. ISG15 deficiency presented with two distinct clinical phenotypes: infectious and neurological. It was identified that both patients are homozygous for the variant (c.83 T > A). Furthermore, it was observed that the mutant protein p.L28Q results in an unstable protein with increased flexibility (ΔΔG: -2.400 kcal/mol). Transcriptome analysis revealed 1321 differentially expressed genes, with significant upregulation in interferon pathways, showing higher expression in patients compared to controls. CONCLUSION: This study describes the first reported cases in Brazil of two unrelated patients with the same ISG15 mutation c.83 T > A, exhibiting infectious features such as mycobacterial infections and systemic candidiasis, neurological findings, and skin lesions, without adverse reactions to the BCG vaccine. CLINICAL IMPLICATIONS: Reporting ISG15 gene mutations in Brazilian patients enhances understanding of genetic susceptibilities, guiding effective diagnostics and treatment. Identifying high-risk individuals aids clinical practices, genetic counseling, and influences public health policies. We have identified the first case in Brazil of the same ISG15 variant c.83 T > A that was identified in two unrelated patients with distinct clinical phenotypes, infectious and neurological. ISG15 deficiency is a mixed syndrome of Mendelian susceptibility to mycobacterial infections (MSMD), a rare inherited condition characterized primarily by recurrent infections from low-virulence mycobacteria and monogenic type I interferonopathy.BACKGROUNDISG15 deficiency is a mixed syndrome of Mendelian susceptibility to mycobacterial infections (MSMD), a rare inherited condition characterized primarily by recurrent infections from low-virulence mycobacteria and monogenic type I interferonopathy.To characterize the laboratory and molecular features of two patients from different families affected by the same ISG15 variant.OBJECTIVETo characterize the laboratory and molecular features of two patients from different families affected by the same ISG15 variant.We began with clinical characterization and investigation, assessed IL-12/IFN-γ production, performed genetic characterization through WES and Sanger sequencing, conducted an in silico molecular analysis of the genetic ISG15 variant's protein impact, and utilized RNAseq for transcriptome analysis to understand pathway impacts on ISG15-deficient subjects from unrelated families.METHODSWe began with clinical characterization and investigation, assessed IL-12/IFN-γ production, performed genetic characterization through WES and Sanger sequencing, conducted an in silico molecular analysis of the genetic ISG15 variant's protein impact, and utilized RNAseq for transcriptome analysis to understand pathway impacts on ISG15-deficient subjects from unrelated families.A mutation in the ISG15 gene was identified, affecting two patients treated in different hospitals and cities in Brazil (Fortaleza and Sao Paulo), who are also members of unrelated families. Both patients showed low IFN-γ production when stimulated with BCG or BCG + IL-12. ISG15 deficiency presented with two distinct clinical phenotypes: infectious and neurological. It was identified that both patients are homozygous for the variant (c.83 T > A). Furthermore, it was observed that the mutant protein p.L28Q results in an unstable protein with increased flexibility (ΔΔG: -2.400 kcal/mol). Transcriptome analysis revealed 1321 differentially expressed genes, with significant upregulation in interferon pathways, showing higher expression in patients compared to controls.RESULTSA mutation in the ISG15 gene was identified, affecting two patients treated in different hospitals and cities in Brazil (Fortaleza and Sao Paulo), who are also members of unrelated families. Both patients showed low IFN-γ production when stimulated with BCG or BCG + IL-12. ISG15 deficiency presented with two distinct clinical phenotypes: infectious and neurological. It was identified that both patients are homozygous for the variant (c.83 T > A). Furthermore, it was observed that the mutant protein p.L28Q results in an unstable protein with increased flexibility (ΔΔG: -2.400 kcal/mol). Transcriptome analysis revealed 1321 differentially expressed genes, with significant upregulation in interferon pathways, showing higher expression in patients compared to controls.This study describes the first reported cases in Brazil of two unrelated patients with the same ISG15 mutation c.83 T > A, exhibiting infectious features such as mycobacterial infections and systemic candidiasis, neurological findings, and skin lesions, without adverse reactions to the BCG vaccine.CONCLUSIONThis study describes the first reported cases in Brazil of two unrelated patients with the same ISG15 mutation c.83 T > A, exhibiting infectious features such as mycobacterial infections and systemic candidiasis, neurological findings, and skin lesions, without adverse reactions to the BCG vaccine.Reporting ISG15 gene mutations in Brazilian patients enhances understanding of genetic susceptibilities, guiding effective diagnostics and treatment. Identifying high-risk individuals aids clinical practices, genetic counseling, and influences public health policies. We have identified the first case in Brazil of the same ISG15 variant c.83 T > A that was identified in two unrelated patients with distinct clinical phenotypes, infectious and neurological.CLINICAL IMPLICATIONSReporting ISG15 gene mutations in Brazilian patients enhances understanding of genetic susceptibilities, guiding effective diagnostics and treatment. Identifying high-risk individuals aids clinical practices, genetic counseling, and influences public health policies. We have identified the first case in Brazil of the same ISG15 variant c.83 T > A that was identified in two unrelated patients with distinct clinical phenotypes, infectious and neurological. ISG15 deficiency is a mixed syndrome of Mendelian susceptibility to mycobacterial infections (MSMD), a rare inherited condition characterized primarily by recurrent infections from low-virulence mycobacteria and monogenic type I interferonopathy. To characterize the laboratory and molecular features of two patients from different families affected by the same ISG15 variant. We began with clinical characterization and investigation, assessed IL-12/IFN-γ production, performed genetic characterization through WES and Sanger sequencing, conducted an in silico molecular analysis of the genetic ISG15 variant's protein impact, and utilized RNAseq for transcriptome analysis to understand pathway impacts on ISG15-deficient subjects from unrelated families. A mutation in the ISG15 gene was identified, affecting two patients treated in different hospitals and cities in Brazil (Fortaleza and Sao Paulo), who are also members of unrelated families. Both patients showed low IFN-γ production when stimulated with BCG or BCG + IL-12. ISG15 deficiency presented with two distinct clinical phenotypes: infectious and neurological. It was identified that both patients are homozygous for the variant (c.83 T > A). Furthermore, it was observed that the mutant protein p.L28Q results in an unstable protein with increased flexibility (ΔΔG: -2.400 kcal/mol). Transcriptome analysis revealed 1321 differentially expressed genes, with significant upregulation in interferon pathways, showing higher expression in patients compared to controls. This study describes the first reported cases in Brazil of two unrelated patients with the same ISG15 mutation c.83 T > A, exhibiting infectious features such as mycobacterial infections and systemic candidiasis, neurological findings, and skin lesions, without adverse reactions to the BCG vaccine. Reporting ISG15 gene mutations in Brazilian patients enhances understanding of genetic susceptibilities, guiding effective diagnostics and treatment. Identifying high-risk individuals aids clinical practices, genetic counseling, and influences public health policies. We have identified the first case in Brazil of the same ISG15 variant c.83 T > A that was identified in two unrelated patients with distinct clinical phenotypes, infectious and neurological. BackgroundISG15 deficiency is a mixed syndrome of Mendelian susceptibility to mycobacterial infections (MSMD), a rare inherited condition characterized primarily by recurrent infections from low-virulence mycobacteria and monogenic type I interferonopathy.ObjectiveTo characterize the laboratory and molecular features of two patients from different families affected by the same ISG15 variant.MethodsWe began with clinical characterization and investigation, assessed IL-12/IFN-γ production, performed genetic characterization through WES and Sanger sequencing, conducted an in silico molecular analysis of the genetic ISG15 variant’s protein impact, and utilized RNAseq for transcriptome analysis to understand pathway impacts on ISG15-deficient subjects from unrelated families.ResultsA mutation in the ISG15 gene was identified, affecting two patients treated in different hospitals and cities in Brazil (Fortaleza and Sao Paulo), who are also members of unrelated families. Both patients showed low IFN-γ production when stimulated with BCG or BCG + IL-12. ISG15 deficiency presented with two distinct clinical phenotypes: infectious and neurological. It was identified that both patients are homozygous for the variant (c.83 T > A). Furthermore, it was observed that the mutant protein p.L28Q results in an unstable protein with increased flexibility (ΔΔG: -2.400 kcal/mol). Transcriptome analysis revealed 1321 differentially expressed genes, with significant upregulation in interferon pathways, showing higher expression in patients compared to controls.ConclusionThis study describes the first reported cases in Brazil of two unrelated patients with the same ISG15 mutation c.83 T > A, exhibiting infectious features such as mycobacterial infections and systemic candidiasis, neurological findings, and skin lesions, without adverse reactions to the BCG vaccine.Clinical ImplicationsReporting ISG15 gene mutations in Brazilian patients enhances understanding of genetic susceptibilities, guiding effective diagnostics and treatment. Identifying high-risk individuals aids clinical practices, genetic counseling, and influences public health policies.Capsule SummaryWe have identified the first case in Brazil of the same ISG15 variant c.83 T > A that was identified in two unrelated patients with distinct clinical phenotypes, infectious and neurological. Background ISG15 deficiency is a mixed syndrome of Mendelian susceptibility to mycobacterial infections (MSMD), a rare inherited condition characterized primarily by recurrent infections from low-virulence mycobacteria and monogenic type I interferonopathy. Objective To characterize the laboratory and molecular features of two patients from different families affected by the same ISG15 variant. Methods We began with clinical characterization and investigation, assessed IL-12/IFN-γ production, performed genetic characterization through WES and Sanger sequencing, conducted an in silico molecular analysis of the genetic ISG15 variant’s protein impact, and utilized RNAseq for transcriptome analysis to understand pathway impacts on ISG15 -deficient subjects from unrelated families. Results A mutation in the ISG15 gene was identified, affecting two patients treated in different hospitals and cities in Brazil (Fortaleza and Sao Paulo), who are also members of unrelated families. Both patients showed low IFN-γ production when stimulated with BCG or BCG + IL-12. ISG15 deficiency presented with two distinct clinical phenotypes: infectious and neurological. It was identified that both patients are homozygous for the variant (c.83 T > A). Furthermore, it was observed that the mutant protein p.L28Q results in an unstable protein with increased flexibility (ΔΔG: -2.400 kcal/mol). Transcriptome analysis revealed 1321 differentially expressed genes, with significant upregulation in interferon pathways, showing higher expression in patients compared to controls. Conclusion This study describes the first reported cases in Brazil of two unrelated patients with the same ISG15 mutation c.83 T > A, exhibiting infectious features such as mycobacterial infections and systemic candidiasis, neurological findings, and skin lesions, without adverse reactions to the BCG vaccine. Clinical Implications Reporting ISG15 gene mutations in Brazilian patients enhances understanding of genetic susceptibilities, guiding effective diagnostics and treatment. Identifying high-risk individuals aids clinical practices, genetic counseling, and influences public health policies. Capsule Summary We have identified the first case in Brazil of the same ISG15 variant c.83 T > A that was identified in two unrelated patients with distinct clinical phenotypes, infectious and neurological. |
| ArticleNumber | 21 |
| Author | Salgado, Ranieri Coelho Barreiros, Lucila Akune de Moura, Thais Costa Lima Gomes, Lillian Nunes Condino-Neto, Antonio Napoleao, Sarah Maria da Silva de Barros Dorna, Mayra França, Tábata Takahashi Ferreira, Janaira Fernandes Severo |
| Author_xml | – sequence: 1 givenname: Sarah Maria da Silva surname: Napoleao fullname: Napoleao, Sarah Maria da Silva email: smnapoleao@gmail.com organization: Department of Immunology, Institute of Biomedical Sciences, University of São Paulo – sequence: 2 givenname: Ranieri Coelho surname: Salgado fullname: Salgado, Ranieri Coelho organization: Department of Immunology, Institute of Biomedical Sciences, University of São Paulo – sequence: 3 givenname: Janaira Fernandes Severo surname: Ferreira fullname: Ferreira, Janaira Fernandes Severo organization: Hospital Infantil Albert Sabin – sequence: 4 givenname: Mayra surname: de Barros Dorna fullname: de Barros Dorna, Mayra organization: Faculty of Medicine, Instituto da Criança E Do Adolescente, Hospital das Clínicas – sequence: 5 givenname: Thais Costa Lima surname: de Moura fullname: de Moura, Thais Costa Lima organization: Faculty of Medicine, Instituto da Criança E Do Adolescente, Hospital das Clínicas – sequence: 6 givenname: Tábata Takahashi surname: França fullname: França, Tábata Takahashi organization: Department of Immunology, Institute of Biomedical Sciences, University of São Paulo – sequence: 7 givenname: Lucila Akune surname: Barreiros fullname: Barreiros, Lucila Akune – sequence: 8 givenname: Lillian Nunes surname: Gomes fullname: Gomes, Lillian Nunes organization: Department of Immunology, Institute of Biomedical Sciences, University of São Paulo – sequence: 9 givenname: Antonio surname: Condino-Neto fullname: Condino-Neto, Antonio email: antoniocondino@gmail.com organization: Department of Immunology, Institute of Biomedical Sciences, University of São Paulo |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39365299$$D View this record in MEDLINE/PubMed |
| BookMark | eNqN0U1v1DAQBmALFdFt4Q9wQJa4cAnMjOOvI6xoWamoCMrZcjYOpMo6i-0Iwa_H7RaQOAAnW_YzHo3fE3YU5xgYe4zwHAH0i4xgtGyA2gbQIDb2Hluh1KIhaemIrYB0PcSWjtlJztcAIBTJB-xYWKEkWbtil2djyoW_Sv77OI0-8rXPgb8P-zkVPg_8Y0xh8iX0_J0vY4gl869j-cw3fd2PWz_xzYdzlPztUur9HB-y-4Ofcnh0t56yq7PXV-s3zcXl-Wb98qLZCkulkeh18AYUdV2PHWnVdWFQBqQ1IILqWwkQRIsaTBsGiZYGjR22LRkpSJyyZ4dn92n-soRc3G7M2zBNPoZ5yU4QKLS2JftvilIY0UoS_0GRjAJLutKnf9DreUmxjnyrrKqtsaond2rpdqF3-zTufPrmfv5_BXQA2zTnnMLwiyC4m5DdIWRXQ3a3IbubInEoyhXHTyH97v2Xqh_OUqSU |
| Cites_doi | 10.1073/pnas.2102804118 10.1084/jem.20211273 10.1111/imr.12272 10.1007/s00439-020-02120-y 10.1016/j.cell.2020.10.046 10.1007/s10875-022-01289-3 10.1016/j.coi.2021.07.001 10.1111/imcb.12210 10.1016/j.ejphar.2011.03.043 10.1126/science.1224026 10.1016/j.molcel.2017.10.003 10.1038/cr.2012.133 10.3390/pathogens13030203 10.1016/j.it.2016.11.001 10.1016/j.smim.2014.09.008 10.1007/s10875-018-0509-8 10.1016/j.celrep.2020.107633 10.1038/nature13801 10.1172/JCI135460 10.1542/peds.2016-1668 10.1016/j.cell.2022.12.038 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. Copyright Springer Nature B.V. Dec 2025 |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. – notice: Copyright Springer Nature B.V. Dec 2025 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 7S9 L.6 |
| DOI | 10.1007/s10875-024-01811-9 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Proquest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA MEDLINE - Academic MEDLINE AGRICOLA ProQuest Central Student |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1573-2592 |
| EndPage | 21 |
| ExternalDocumentID | 39365299 10_1007_s10875_024_01811_9 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Case Reports |
| GeographicLocations | Brazil |
| GeographicLocations_xml | – name: Brazil |
| GrantInformation_xml | – fundername: Fundação de Amparo à Pesquisa do Estado de São Paulo grantid: 2016/22158-3; 2016/22158-3; 2016/22158-3; 2016/22158-3; 2016/22158-3; 2016/22158-3 funderid: http://dx.doi.org/10.13039/501100001807 – fundername: Fundação de Amparo à Pesquisa do Estado de São Paulo grantid: 2016/22158-3 |
| GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29K 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3SX 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67N 67Z 6NX 78A 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AAJSJ AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACULB ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFFNX AFGCZ AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BSONS BVXVI C6C CAG CCPQU COF CS3 CSCUP D-I DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAK LK8 LLZTM M1P M4Y M7P MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI RNS ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW VVN W23 W48 WJK WK6 WK8 Y6R YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABEEZ ABFSG ACSTC ADHKG AEZWR AFDZB AFGXO AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PQGLB PUEGO CGR CUY CVF ECM EIF NPM 7T5 7XB 8FK AZQEC DWQXO GNUQQ H94 K9. PKEHL PQEST PQUKI PRINS 7X8 7S9 L.6 |
| ID | FETCH-LOGICAL-c392t-51a7ea8062bbd1b276bbef68059803e6d4500e3417084ef5192f71b144285323 |
| IEDL.DBID | U2A |
| ISSN | 0271-9142 1573-2592 |
| IngestDate | Thu Oct 02 23:02:09 EDT 2025 Fri Oct 03 00:10:55 EDT 2025 Sun Sep 28 00:26:01 EDT 2025 Mon Oct 06 18:02:45 EDT 2025 Wed Feb 19 02:02:00 EST 2025 Wed Oct 01 03:53:32 EDT 2025 Fri Feb 21 02:47:46 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | primary immunodeficiency MSMD inborn errors of immunity mycobacterial infections IL-12/IFN-γ axis ISG15 deficiency |
| Language | English |
| License | 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c392t-51a7ea8062bbd1b276bbef68059803e6d4500e3417084ef5192f71b144285323 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Report-3 ObjectType-Case Study-4 |
| PMID | 39365299 |
| PQID | 3112964291 |
| PQPubID | 24069 |
| PageCount | 1 |
| ParticipantIDs | proquest_miscellaneous_3206199429 proquest_miscellaneous_3153834523 proquest_miscellaneous_3112860927 proquest_journals_3112964291 pubmed_primary_39365299 crossref_primary_10_1007_s10875_024_01811_9 springer_journals_10_1007_s10875_024_01811_9 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2025-12-01 |
| PublicationDateYYYYMMDD | 2025-12-01 |
| PublicationDate_xml | – month: 12 year: 2025 text: 2025-12-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | New York |
| PublicationPlace_xml | – name: New York – name: Netherlands |
| PublicationSubtitle | International Journal of Inborn Errors of Immunity and Related Diseases |
| PublicationTitle | Journal of clinical immunology |
| PublicationTitleAbbrev | J Clin Immunol |
| PublicationTitleAlternate | J Clin Immunol |
| PublicationYear | 2025 |
| Publisher | Springer US Springer Nature B.V |
| Publisher_xml | – name: Springer US – name: Springer Nature B.V |
| References | A Dalvi (1811_CR8) 2024; 13 J Rosain (1811_CR10) 2023; 186 CD Swaim (1811_CR18) 2017; 68 JB Fan (1811_CR20) 2013; 23 S Boisson-Dupuis (1811_CR4) 2015; 264 J Bustamante (1811_CR1) 2014; 26 J Rosain (1811_CR9) 2019; 97 TL Voyer (1811_CR13) 2021; 118 J Bustamante (1811_CR6) 2020; 139 D Bogunovic (1811_CR17) 2012; 337 M Martin-Fernandez (1811_CR14) 2020; 31 SG Tangye (1811_CR21) 2022; 42 AC Almeida (1811_CR5) 2011; 660 G Kerner (1811_CR11) 2020; 130 X Zhang (1811_CR19) 2015; 517 R Yang (1811_CR12) 2020; 183 S Boisson-Dupuis (1811_CR7) 2021; 72 M Hermann (1811_CR15) 2017; 38 B Glanzmann (1811_CR3) 2018; 38 1811_CR2 M Martin-Fernandez (1811_CR16) 2022; 219 |
| References_xml | – volume: 118 start-page: e2102804118 year: 2021 ident: 1811_CR13 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.2102804118 – volume: 219 start-page: e20211273 issue: 4 year: 2022 ident: 1811_CR16 publication-title: J Exp Med. doi: 10.1084/jem.20211273 – volume: 264 start-page: 103 year: 2015 ident: 1811_CR4 publication-title: Immunol Rev doi: 10.1111/imr.12272 – volume: 139 start-page: 993 issue: 6–7 year: 2020 ident: 1811_CR6 publication-title: Human Genet doi: 10.1007/s00439-020-02120-y – volume: 183 start-page: 1826 year: 2020 ident: 1811_CR12 publication-title: Cell doi: 10.1016/j.cell.2020.10.046 – volume: 42 start-page: 1473 issue: 7 year: 2022 ident: 1811_CR21 publication-title: J Clin Immunol doi: 10.1007/s10875-022-01289-3 – volume: 72 start-page: 262 year: 2021 ident: 1811_CR7 publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2021.07.001 – volume: 97 start-page: 360 year: 2019 ident: 1811_CR9 publication-title: Immunol Cell Biol doi: 10.1111/imcb.12210 – volume: 660 start-page: 445 year: 2011 ident: 1811_CR5 publication-title: Eur J Pharm doi: 10.1016/j.ejphar.2011.03.043 – volume: 337 start-page: 1684 year: 2012 ident: 1811_CR17 publication-title: Science doi: 10.1126/science.1224026 – volume: 68 start-page: 581 issue: 3 year: 2017 ident: 1811_CR18 publication-title: Mol Cell doi: 10.1016/j.molcel.2017.10.003 – volume: 23 start-page: 173 year: 2013 ident: 1811_CR20 publication-title: Cell Res doi: 10.1038/cr.2012.133 – volume: 13 start-page: 203 issue: 3 year: 2024 ident: 1811_CR8 publication-title: Pathogens. doi: 10.3390/pathogens13030203 – volume: 38 start-page: 79 issue: 2 year: 2017 ident: 1811_CR15 publication-title: Trends Immunol. doi: 10.1016/j.it.2016.11.001 – volume: 26 start-page: 454 year: 2014 ident: 1811_CR1 publication-title: Seminary Immunol doi: 10.1016/j.smim.2014.09.008 – volume: 38 start-page: 460 year: 2018 ident: 1811_CR3 publication-title: J Clin Immunol doi: 10.1007/s10875-018-0509-8 – volume: 31 start-page: 107633 issue: 6 year: 2020 ident: 1811_CR14 publication-title: Cell Rep doi: 10.1016/j.celrep.2020.107633 – volume: 517 start-page: 89 year: 2015 ident: 1811_CR19 publication-title: Nature doi: 10.1038/nature13801 – volume: 130 start-page: 3158 year: 2020 ident: 1811_CR11 publication-title: J Clin Investig doi: 10.1172/JCI135460 – ident: 1811_CR2 doi: 10.1542/peds.2016-1668 – volume: 186 start-page: 621 issue: 3 year: 2023 ident: 1811_CR10 publication-title: Cell. doi: 10.1016/j.cell.2022.12.038 |
| SSID | ssj0003625 |
| Score | 2.4556227 |
| Snippet | Background
ISG15 deficiency is a mixed syndrome of Mendelian susceptibility to mycobacterial infections (MSMD), a rare inherited condition characterized... ISG15 deficiency is a mixed syndrome of Mendelian susceptibility to mycobacterial infections (MSMD), a rare inherited condition characterized primarily by... BackgroundISG15 deficiency is a mixed syndrome of Mendelian susceptibility to mycobacterial infections (MSMD), a rare inherited condition characterized... BACKGROUND: ISG15 deficiency is a mixed syndrome of Mendelian susceptibility to mycobacterial infections (MSMD), a rare inherited condition characterized... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 21 |
| SubjectTerms | BCG vaccine Biomedical and Life Sciences Biomedicine Brazil Candidiasis case studies Child Child, Preschool computer simulation Cytokines - metabolism diagnostic techniques Female gene expression regulation genes Genetic analysis Genetic counseling Genetic Predisposition to Disease homozygosity Humans Immunology Infant Infections Infectious Diseases Interferon-gamma - genetics interferons Interleukin 12 Internal Medicine Male Medical Microbiology mutants Mutation Mutation - genetics Mycobacterium Infections - diagnosis Mycobacterium Infections - etiology Mycobacterium Infections - genetics Patients Pedigree Phenotype Phenotypes Point mutation Protein structure Proteins Public health Skin diseases Skin lesions Transcriptomes transcriptomics Ubiquitins - genetics Virulence γ-Interferon |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED90AxFEdH7VLyL4psE2TdPmQURlcwqb4gf4VpomBV86P7YX_3ovTbsh4l76kkCTu-Tud3e5O4BjPzCsMFpSw_KQch7nVAqOn8xmlvAk11Xh-cFQ9F_43Wv0ugDDJhfGPqtsZGIlqPUotz7ys9ACAwTLMrh4_6C2a5SNrjYtNLK6tYI-r0qMLUKb2cpYLWhfdYcPj1PZjOK6etTI4gCvOWd1Gk2dTIfYnaLOoraIFY7_VlV_8Oef2GmlknprsFpjSXLpmL8OC6bswNKgjpZ3YMX55IhLNdqA-94bYj1y9Zl9v1nvBrlGFUYcBCejgryUVWaL0eTBVVv9ItZNS1wyLzKT3D7dBBEZTFz8fhOee93n6z6tGyrQHGHQmEZBFpss8QVTSgeKxUIpU4gEIVbih0ZoHvm-Qb0W-wk3BYI7VsSBQpuLoVZn4Ra0ylFpdoDkuVQKTQ1tEsRTBc_Q0uUiMFEWCa517MFJQ7r03ZXNSGcFki2hUyR0WhE6lR7sN9RN6yv0lc4Y7sHRdBgPv41oZKUZTdycRPiSxfPmoEwPORrcc-YwhDVS4s882HbcnS47lKGIUGl7cNqwe7bI__e0O39Pe7DMbCfh6mHMPrTGnxNzgPBmrA7rM_sDRWPyWw priority: 102 providerName: ProQuest |
| Title | First Brazilian Case Report of Unrelated Patients with Identical ISG15 Mutation |
| URI | https://link.springer.com/article/10.1007/s10875-024-01811-9 https://www.ncbi.nlm.nih.gov/pubmed/39365299 https://www.proquest.com/docview/3112964291 https://www.proquest.com/docview/3112860927 https://www.proquest.com/docview/3153834523 https://www.proquest.com/docview/3206199429 |
| Volume | 45 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1573-2592 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003625 issn: 0271-9142 databaseCode: AFBBN dateStart: 19970101 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1573-2592 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003625 issn: 0271-9142 databaseCode: 7X7 dateStart: 20250101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1573-2592 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003625 issn: 0271-9142 databaseCode: BENPR dateStart: 20250101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1573-2592 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003625 issn: 0271-9142 databaseCode: 8C1 dateStart: 20250101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVAVX databaseName: HAS SpringerNature Open Access 2022 customDbUrl: eissn: 1573-2592 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003625 issn: 0271-9142 databaseCode: AAJSJ dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1573-2592 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003625 issn: 0271-9142 databaseCode: C6C dateStart: 20250101 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1573-2592 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003625 issn: 0271-9142 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1573-2592 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0003625 issn: 0271-9142 databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_WBEZfSrdundsuaNC3VWDJsmQ9Jibpx0hW1gayJ2PZMuTFGfl46V_fkz-SlX5AX2SwD1u6k-9-p9OdAM59Znlhc00tzwIqhMqolgKb1GWWiCjLq8Lz44m8moqbWThrksJW7W73NiRZaer_kt0QW1O0KdQVmWJU70E3dOW8cBZPeX-rf1ElVxsXuUIaJniTKvPyO56ao2cY81l8tDI7o0M4aPAi6dcC_gQfbPkZPo6biPgR_B7NEb-RwTJ9mLsVCxKjWSI1rCaLgkzLKlvF5uS2rqC6Im7pldQJuiggcn13yUIy3tQx-S9wPxrex1e0OSSBZght1jRkqbJp5EtuTM4MV9IYW8gIYVPkB1bmIvR9i7ZK-ZGwhWNYoZhBP4qjpebBV-iUi9J-A5Jl2hh0H3IbIUYqRIreq5DMhmkoRZ4rD362rEr-1aUwkl3RY8fYBBmbVIxNtAdnLTeT5rdYJYFDd-jxaObBj-1jnNAuSpGWdrGpaSLpa67eokE9HQh0ot-g4QhVtMaPeXBcS3Pb7UAHMkRD7MFFK95dJ18f08n7yE9hn7vTgqvNL2fQWS839jtCmLXpwZ6aKWyjmPWg27_8-2uI18FwcvsH78Yy7lVz-hGp5emV |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fT9swED9VIG1IE9oYbGHdMNJ4AovEcZz4AU1bR2kHhUkUiTcrjh2Jl5TRVmj7TvuOnOOEakLrGy95saXY5_Pd73z_AD6HkWWlNZJaVsSU87SgUnD85C6zhGeFqQvPj87F4Ir_uE6uO_C3zYVxYZWtTKwFtZkU7o38MHbAAMGyjL7c_qKua5TzrrYtNDxbnNrf92iyTY-G3_F89xjrH497A9p0FaAFYoEZTaI8tXkWCqa1iTRLhda2FBnijCyMrTA8CUOLwj0NM25LRDisTCONhgdD1ebqHKDEX-UxS50cyHqLiBLUBXXEJI6gDOGsydFpMvXQMKCoEKmrkIXj_-rBJ-D2iWO21nf917DeAFXy1XPWG-jYagNejBpX_Aa88g9-xOcxvYWL_g0CSfLtLv9z455OSA_1I_H4nkxKclXVaTPWkJ--lOuUuDdg4jOFkVPI8PIkSsho7oMDNmH8HHTdgpVqUtn3QIpCao12jLEZgrWS52hGcxHZJE8ENyYNYL8lnbr1NTnUovqyI7RCQqua0EoG0G2pq5r7OVULbgpg93EYb5Zzl-SVncz9nEyEkqXL5qDCiDla80vmMMRMUuLPAnjnT_dx2bGMRYKIIICD9rgXi_z_nraX72kHXg7GozN1Njw__QBrzLUsriNwurAyu5vbj4ijZvpTzb0E1DPflgeKUyWV |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9wwEB5CCqFQQpM-4ryqQntqRWxZlqxDCHl0m226aaAJ7E1Ylgy5eJPsLqX9Z_13GVn2LiFkb7n4IoGl0Wjmm9E8AD7FiWOVs4o6VqaUc1lSJTh-Cp9ZwvPSNoXnB-fi9Ir_GGbDJfjf5cL4sMpOJjaC2o5K7yPfSz0wQLCskr2qDYu4OOkd3NxS30HKv7R27TQCi5y5v3_QfBvv90_wrD8z1vt2eXxK2w4DtERcMKFZUkhX5LFgxtjEMCmMcZXIEXPkceqE5VkcOxT0Ms65qxDtsEomBo0QhmrO1zxA6f9Cpqny0YRyOLP1vF5ooieZTFCecNbm67RZe2gkUFSO1FfLwvGHOvER0H30SNvovt5rWG1BKzkMXLYGS65eh5VB-yy_Dq-C84-EnKY38Kt3jaCSHN0V_669G4Uco64kAeuTUUWu6iaFxllyEcq6jon3B5OQNYxcQ_q_vycZGUxDoMBbuHwOur6D5XpUuw0gZamMQZvGuhyBW8ULNKm5SFxWZIJbKyP40pFO34T6HHpeidkTWiOhdUNorSLY7qir27s61nPOiuDjbBhvmX86KWo3moY5uYgVk4vmoPJIOVr2C-YwxE9K4c8ieB9Od7bsVKUiQ3QQwdfuuOeLfHpPm4v39AFW8J7on_3zsy14yXz34iYYZxuWJ3dTt4OQamJ2G-YloJ_5stwDBoQqBA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=First+Brazilian+Case+Report+of+Unrelated+Patients+with+Identical+ISG15+Mutation&rft.jtitle=Journal+of+clinical+immunology&rft.au=Napoleao%2C+Sarah+Maria+da+Silva&rft.au=Salgado%2C+Ranieri+Coelho&rft.au=Ferreira%2C+Janaira+Fernandes+Severo&rft.au=de+Barros+Dorna%2C+Mayra&rft.date=2025-12-01&rft.issn=0271-9142&rft.volume=45&rft.issue=1+p.21-21&rft.spage=21&rft.epage=21&rft_id=info:doi/10.1007%2Fs10875-024-01811-9&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-9142&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-9142&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-9142&client=summon |